Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy
ProPNIVFlow
2 other identifiers
interventional
100
0 countries
N/A
Brief Summary
The aim of this trial is to study the effect of prone position during NIV and HFNC on acute hypoxemic respiratory patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2020
CompletedFirst Posted
Study publicly available on registry
March 12, 2020
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedAugust 30, 2021
August 1, 2021
2 months
March 10, 2020
August 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oro-tracheal entubation
Oro-tracheal entubation avoidance
1 month
Secondary Outcomes (1)
PaO2/FiO2
1 month
Study Arms (4)
NIV with prone position
EXPERIMENTALUse of prone position during NIV
NIV (conventional)
PLACEBO COMPARATORNIV on conventional position
HFNC on prone position
EXPERIMENTALProne position during HFNC
HFNC (conventional)
PLACEBO COMPARATORHFNC on conventional position
Interventions
HFNC and NIV application with patient on prone position
Eligibility Criteria
You may qualify if:
- Adult patients with:
- ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
You may not qualify if:
- General NIV or HFNC contraindications
- Immediate need for IOT
- Prone position intolerance
- Patients refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 10, 2020
First Posted
March 12, 2020
Study Start
September 1, 2021
Primary Completion
November 1, 2021
Study Completion
May 1, 2022
Last Updated
August 30, 2021
Record last verified: 2021-08